Iveric Bio announces FDA approval for IZERVAY™️️

Iveric Bio announces FDA approval for IZERVAY™️️

Iveric Bio announces FDA approval for IZERVAY™️️

Congratulations to Iveric Bio for their FDA approval for IZERVAY™️️, a new treatment for Geographic Atrophy (GA). Modality Solutions is proud to have been a part of its cold chain strategy!

Read the full press release here.

View all blogs

Stay on top of the industry trends

Now offering expertise to support pharmaceuticals, biologics, and medical device development from discovery through commercialization as a BlueRidge Life Sciences Company.